Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumors.
第一作者:
Jeong Ho,Yoon
第一单位:
Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
作者:
医学主题词
动物(Animals);间质干细胞(Mesenchymal Stem Cells);趋化因子CXCL10(Chemokine CXCL10);免疫疗法, 过继(Immunotherapy, Adoptive);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);间质干细胞移植(Mesenchymal Stem Cell Transplantation);细胞系, 肿瘤(Cell Line, Tumor);肿瘤微环境(Tumor Microenvironment);人类(Humans);T淋巴细胞(T-Lymphocytes);女(雌)性(Female);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);NAD(P)H脱氢酶(醌)(NAD(P)H Dehydrogenase (Quinone));肿瘤(Neoplasms)
DOI
10.1016/j.biopha.2025.118579
PMID
40975901
发布时间
2025-11-14
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



